Skip to main content

Advertisement

Log in

Breast sentinel lymph node navigation with three-dimensional computed tomography–lymphography: a 12-year study

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the utility of three-dimensional (3D) computed tomography (CT)−lymphography (LG) breast sentinel lymph node navigation in our institute.

Patients and methods

Between 2002 and 2013, we preoperatively identified sentinel lymph nodes (SLNs) in 576 clinically node-negative breast cancer patients with T1 and T2 breast cancer using 3D CT–LG method. SLN biopsy (SLNB) was performed in 557 of 576 patients using both the images of 3D CT–LG for guidance and the blue dye method.

Results

Using 3D CT–LG, SLNs were visualized in 569 (99 %) of 576 patients. Of 569 patients, both lymphatic draining ducts and SLNs from the peritumoral and periareolar areas were visualized in 549 (96 %) patients. Only SLNs without lymphatic draining ducts were visualized in 20 patients. Drainage lymphatic pathways visualized with 3D CT–LG (549 cases) were classified into four patterns: single route/single SLN (355 cases, 65 %), multiple routes/single SLN (59 cases, 11 %) single route/multiple SLNs (62 cases, 11 %) and multiple routes/multiple SLNs (73 cases, 13 %). SLNs were detected in 556 (99.8 %) of 557 patients during SLNB.

Conclusion

CT–LG is useful for preoperative visualization of SLNs and breast lymphatic draining routes. This preoperative method should contribute greatly to the easy detection of SLNs during SLNB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–7.

    Article  CAS  PubMed  Google Scholar 

  2. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365–83.

    Article  PubMed  Google Scholar 

  5. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.

    Article  CAS  PubMed  Google Scholar 

  6. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297–305.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Suga K, Ogasawara N, Yuan Y, Okada M, Matsunaga N, Tangoku A. Visualization of breast lymphatic pathways with an indirect CT lymphography using a nonionic monometric contrast medium iopamidol: preliminary results. Invest Radiol. 2003;38:73–84.

    Article  PubMed  Google Scholar 

  8. Tangoku A, Yamamoto S, Suga K, Ueda K, Nagashima Y, Hida M, et al. Sentinel lymph node biopsy using computed tomography–lymphography in patients with breast cancer. Surgery. 2004;135:258–65.

    Article  PubMed  Google Scholar 

  9. Suga K, Yamamoto S, Tangoku A, Oka M, Kawakami Y, Matsunaga N. Breast sentinel lymph node navigation with three-dimensional interstitial multidetector-row computed tomographic lymphography. Invest Radiol. 2005;40:336–42.

    Article  PubMed  Google Scholar 

  10. Yamamoto S, Maeda N, Tamesa M, Nagashima Y, Suga K, Oka M. Sentinel lymph node detection in breast cancer patients by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography. Breast J. 2010;16:4–8.

    Article  PubMed  Google Scholar 

  11. Yamamoto S, Maeda N, Tamesa M, Nagashima Y, Yoshimura K, Oka M. Prospective ultrasonographic prediction of sentinel lymph node metastasis by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography in breast cancer patients. Breast Cancer. 2012;19:77–82.

    Article  PubMed  Google Scholar 

  12. Yamamoto S, Maeda N, Yoshimura K, Oka M. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography. Breast. 2013;22:933–7.

    Article  PubMed  Google Scholar 

  13. Cody HS 3rd. Sentinal lymph node mapping in breast cancer. Breast Cancer. 1999;25:13–22.

    Article  Google Scholar 

  14. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16.

    Article  PubMed  Google Scholar 

  15. Iwasaki T, Mikami E, Shimosegawa T, Arai O, Mitake T (2004) Real-time virtual sonography: a novel navigation tool in percutaneous radiofrequency ablation of hepatocellular carcinomas. In: Radiological Society of North America scientific assembly and annual meeting program. Oak Brook: Radiological Society of North America, p 392.

  16. Nakano S, Yoshida M, Fujii K, Yorozuya K, Mouri Y, Kousaka J, et al. Fusion of MRI and sonography image for breast cancer evaluation using real-time virtual sonography with magnetic navigation: first experience. Jpn J Clin Oncol. 2009;39:552–9.

    Article  PubMed  Google Scholar 

  17. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.

    Article  PubMed  Google Scholar 

  19. Postma EL, van Wieringen S, Hobbelink MG, Verkooijen HM, van den Bongard HJ, Borel Rinkes IH, et al. Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat. 2012;134:735–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Heuts EM, van der Ent FW, von Meyenfeldt MF, Voogd AC. Internal mammary lymph drainage and sentinel node biopsy in breast cancer: a study on 1008 patients. Eur J Surg Oncol. 2009;35:252–7.

    Article  CAS  PubMed  Google Scholar 

  21. Qiu PF, Liu JJ, Liu YB, Yang GR, Sun X, Wang YS. A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat. 2012;136:319–21.

    Article  PubMed  Google Scholar 

  22. Shimazu K, Tamaki Y, Taguchi T, Motomura K, Inaji H, Koyama H, et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg. 2003;237:390–8.

    PubMed  PubMed Central  Google Scholar 

  23. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography–lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;9(13):42.

    Article  Google Scholar 

  24. Yokohata K, Hattori M, Fujimoto T, Chikazawa N, Maeyama R, Yamanaka N, et al. Computed tomographic lymphography predicts the difficulty of sentinel lymph node biopsy with dye. Breast Cancer. 2014;21:198–201.

    Article  PubMed  Google Scholar 

  25. Tan H, Yang B, Wu J, Wana S, Gu Y, Li W, et al. Localization and evaluation of sentinel lymph node in breast cancer from computed tomographic lymphography. J Comput Assist Tomogr. 2011;35:367–74.

    Article  PubMed  Google Scholar 

  26. Minohata J, Takao S, Hirokaga K. Sentinel lymph node biopsy using CT lymphography in breast cancer. Breast Cancer. 2011;18:129–36.

    Article  PubMed  Google Scholar 

  27. Yamashita K, Shimizu K. Video-assisted breast surgery can sample the second and third sentinel nodes to omit axillary node dissection for sentinel-node-positive patients. Surg Endosc. 2009;23:1574–80.

    Article  CAS  PubMed  Google Scholar 

  28. Takahashi M, Sasa M, Hirose C, Hisaoka S, Taki M, Hirose T, et al. Clinical efficacy and problems with CT lymphography in identifying the sentinel node in breast cancer. World J Surg Oncol. 2008;12(6):57.

    Article  Google Scholar 

  29. Yamashita K, Shimizu K. Video-assisted breast surgery and sentinel lymph node biopsy guided by three-dimensional computed tomographic lymphography. Surg Endosc. 2008;22:392–7.

    Article  CAS  PubMed  Google Scholar 

  30. Minato M, Hirose C, Sasa M, Nishitani H, Hirose Y, Morimoto T. 3-dimensional computed tomography lymphography-guided identification of sentinel lymph nodes in breast cancer patients using subcutaneous injection of nonionic contrast medium: a clinical trial. J Comput Assist Tomogr. 2004;28:46–51.

    Article  PubMed  Google Scholar 

  31. Yamashita K, Shimizu K. Evaluation of sentinel lymph node metastasis alone guided by three-dimensional computed tomographic lymphography in video-assisted breast surgery. Surg Endosc. 2009;23:633–40.

    Article  CAS  PubMed  Google Scholar 

  32. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.

    Article  PubMed  Google Scholar 

  33. Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20:2213–8.

    Article  PubMed  Google Scholar 

  34. Kitai T, Kawashima M. Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer. 2012;19:343–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeru Yamamoto.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto, S., Suga, K., Maeda, K. et al. Breast sentinel lymph node navigation with three-dimensional computed tomography–lymphography: a 12-year study. Breast Cancer 23, 456–462 (2016). https://doi.org/10.1007/s12282-015-0584-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-015-0584-0

Keywords

Navigation